Could Your Kid Benefit From Counseling? Experts Offer 3 Questions To Help You Decide

0:00 0:00 Produced in partnership with: Embed Download Volume Speed 0.5x 1x 1.25x 1.5x 2x Embed this player × <iframe src=”https://kffhealthnews.org/mental-health/healthq-children-therapy-experts-help-parents-decide/embed/” width=”600″ height=”200″ frameborder=”0″ scrolling=”no” title=”Could Your Kid Benefit From Counseling? Experts Offer 3 Questions To Help You Decide”></iframe> Copy HealthQ’s Cara Anthony and Blake Farmer share know-how for parents navigating the decision to seek…

Read More

Can AI Break the “Measurement Paradigm?”

How do we know if AI use in health care actually makes patients better? Chip talks with Dr. David Bates — a veteran physician leader at Mass General Brigham and the Brigham and Women’s Hospital and Co-director of the Center for Artificial Intelligence and Bioinformatics Learning Systems — about measuring patient outcomes reliably and in…

Read More

HHS Affordability Czar Says Healthcare Costs Stem From Incentives, Not Coverage

Healthcare affordability czar Casey Mulligan laid out the economic philosophy guiding the Trump administration’s approach to healthcare costs during a recent conference address. He argued that provider taxes and state-directed payments inflate healthcare spending far beyond Medicaid and ultimately raise costs for employers and taxpayers. The post HHS Affordability Czar Says Healthcare Costs Stem From…

Read More

Incyte’s $1.25B Buyout Brings What Could Become the Next Big Bleeding Disorder Drug

Incyte’s Vega Therapeutics acquisition comes with a late-stage drug offering a novel mechanism of action and a dosing advantage compared to currently available therapies for von Willebrand disease, an inherited bleeding disorder. The deal comes as patent expiration looms for Jakafi, currently Incyte’s top product. The post Incyte’s $1.25B Buyout Brings What Could Become the…

Read More

How AI is Unlocking Smarter Clinical Trial Protocols

By fine-tuning domain-specific models with real clinical operations data — such as historical performance, feasibility outcomes, enrollment patterns, and resource utilization — hidden information can be translated into structured intelligence. The post How AI is Unlocking Smarter Clinical Trial Protocols appeared first on MedCity News.

Read More